Comparison on simultaneous caillary and venous parasite density and genotyping results from children and adults with uncomplicated malaria: a prospective observational study in Uganda

BMC Infect Dis. 2019 Jun 26;19(1):559. doi: 10.1186/s12879-019-4174-1.

Abstract

Background: Blood smear microscopy remains the gold-standard method to diagnose and quantify malaria parasite density. In addition, parasite genotyping of select loci is the most utilized method for distinguishing recrudescent and new infections and to determine the number of strains per sample. In research settings, blood may be obtained from capillary or venous compartments, and results from these matrices have been used interchangeably. Our aim was to compare quantitative results for parasite density and strain complexity from both compartments.

Methods: In a prospective observational study, children and adults presenting with uncomplicated Plasmodium falciparum malaria, simultaneous capillary and venous blood smears and dried blood spots were collected over 42-days following treatment with artemether-lumefantrine. Blood smears were read by two microscopists, any discrepancies resolved by a third reader. Parasite DNA fingerprinting was conducted using six microsatellites. Bland Altman analysis and paired t-test/McNemar's test were used to assess the difference in density readings and measurements.

Results: Two hundred twenty-three participants were included in the analysis (177 children (35 HIV-infected/142 HIV-uninfected), 21 HIV-uninfected pregnant women, and 25 HIV-uninfected non-pregnant adults). Parasite density measurements did not statistically differ between capillary and venous blood smears at the time of presentation, nor over the course of 42-day follow-up. Characterization of merozoite surface protein-2 (MSP-2) genetic polymorphism demonstrated a higher level of strain diversity at the time of presentation in venous samples, as compared with capillary specimens (p = 0.02). There was a high degree of variability in genotype-corrected outcomes when pairs of samples from each compartment were compared using MSP-2 alone, although the variability was reduced with the use of multiple markers.

Conclusions: Parasite density measurements do not statistically differ between capillary and venous compartments in all studied demographic groups at the time of presentation with malaria, or over the course of follow-up. More strains were detected by MSP-2 genotyping in venous samples than in capillary samples at the time of malaria diagnosis. The use of multiple polymorphic markers reduces the impact of variability in strain detection on genotype-corrected outcomes. This study confirms that both capillary and venous compartments can be used for sampling with confidence in the clinical research setting.

Trial registration: The trial was registered at ClinicalTrials.gov under registration no. NCT01717885 .

Keywords: Antimalarial; Capillary; Complexity of infection; Genotyping; Malaria; Microscopy; Parasite density; Parasitemia; Strain diversity; Uganda; Venous.

Publication types

  • Observational Study

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / parasitology
  • Adolescent
  • Adult
  • Aged
  • Animals
  • Antimalarials / pharmacokinetics
  • Antimalarials / therapeutic use
  • Artemether, Lumefantrine Drug Combination / pharmacokinetics
  • Artemether, Lumefantrine Drug Combination / therapeutic use
  • Capillaries / parasitology*
  • Child
  • Child, Preschool
  • Drug Monitoring / methods
  • Female
  • Genotype
  • Genotyping Techniques / methods
  • HIV
  • HIV Infections / complications
  • HIV Infections / parasitology
  • Humans
  • Infant
  • Malaria, Falciparum / blood
  • Malaria, Falciparum / diagnosis
  • Malaria, Falciparum / drug therapy
  • Malaria, Falciparum / parasitology*
  • Male
  • Middle Aged
  • Parasite Load / methods*
  • Parasitemia / blood
  • Parasitemia / complications
  • Parasitemia / diagnosis
  • Parasitemia / drug therapy
  • Plasmodium falciparum / genetics*
  • Plasmodium falciparum / isolation & purification
  • Uganda
  • Veins / parasitology*
  • Young Adult

Substances

  • Antimalarials
  • Artemether, Lumefantrine Drug Combination

Associated data

  • ClinicalTrials.gov/NCT01717885